Skip to main content Skip to secondary navigation

Docket #: S06-398A

Genetically-Targetable Optical Inactivation of Excitable Cells

The inventors have developed a light-driven chloride pump (NpHR or Halo) for temporally precise optical inhibition of neural activity with ordinary yellow light. The inventors have also demonstrated that NpHR can be used to correct aberrant neural activity in the millisecond timescale.

NpHR is compatible with ChR2, an optical excitation technology (see Stanford Docket S05-170), in that the two opposing probes operate at similar light powers but with well-separated action spectra. NpHR and ChR2 can be used simultaneously to create bidirectional optical control of neural activity with blue and yellow light.

Additional optical control of neural circuitry using NpHR is described in Stanford Docket S06-398.

Applications

  • Research:
    • basic studies for understanding neural circuitry
    • in animal models to identify control points for neurological and psychiatric diseases
  • Drug screening - for drugs that affect hyperpolarization-activated channels
  • Therapeutic - optically activated prosthetics for bidirectional control of neurons or neural inhibition as a potential alternative to tissue ablation or surgery

Advantages

  • When combined with the engineered ChR2, the NpHR/ChR2 system enables rapid bidirectional control of neurons on the timescale of milliseconds, thus enabling emulation or alteration of the neural code. These fast genetically based, neural-spike-controlling technologies powerfully augment existing tools for interrogating neural systems.

Publications

Patents

Similar Technologies

Explore similar technologies by keyword: